Amphastar Pharmaceuticals
AMPH
AMPH
104 hedge funds and large institutions have $363M invested in Amphastar Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Holders
104
Holding in Top 10
–
Calls
–
Puts
$8K
Top Buyers
| 1 | +$4.04M | |
| 2 | +$2.1M | |
| 3 | +$1.94M | |
| 4 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$1.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$769K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$2.39M | |
| 3 | -$1.65M | |
| 4 |
Morgan Stanley
New York
|
-$1.18M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.07M |